Hope for ischemic brain injury

“This is a whole new paradigm, a totally different way of targeting disease,” says Dr. David Hess, Chair of the Department of Neurology, Georgia Medical College.

NIH trials using intravenously transplanted bone marrow cells are under consideration for stroke and cerebral palsy. The chief investigators believe the real beneficiaries of this type of therapy will be babies affected by cerebral palsy. The transplants may halt the range of cell damage that can occur even days after a stroke. Read more about this fascinating investigation, here.